首页 | 本学科首页   官方微博 | 高级检索  
检索        

创建以过程管控为核心的中药质量控制技术体系
引用本文:程翼宇,钱忠直,张伯礼.创建以过程管控为核心的中药质量控制技术体系[J].中国中药杂志,2017,42(1):1-5.
作者姓名:程翼宇  钱忠直  张伯礼
作者单位:浙江大学 中药科学与工程学系, 浙江 杭州 310058,国家药典委员会, 北京 100061,天津中医药大学, 天津 300193;中国中医科学院, 北京 100700
基金项目:国家自然科学基金项目(8160140154);教育部新世纪优秀人才项目(NCET-13-0936);国家“重大新药创制”科技重大专项(2011ZX09304-08)
摘    要:该文首先简述中药质量控制技术现状、瓶颈问题及严峻的挑战,提出应改变以事后检验为主要手段而不重视过程管控的药品监管现象,扭转业界忽视发展制药过程管控技术的局面,重构中药产品质量控制技术体系;通过建立以制药过程管控为核心的中药质量控制技术和监管体系,从根本上解决质量控制技术落后、质量风险管控措施不力、产品质量声誉不高等中药行业重大现实问题,从而突破中成药产品质量可控性差等难关。围绕中药质量控制技术领域中的难点问题和薄弱环节,提议尽快构建具有中国原创特色的中药CMC(chemistry,manufacturing and controls)技术规则并推动其得到国际认可,同时设计了以临床疗效为导向、制造方式为主轴、过程控制为重点的中药CMC技术架构。根据中医药临床特色及中成药生产特点,建议将药物分析学与中药化学、中药药理学、制药工程学、控制工程学、管理工程学等学科相结合,创立中药质量控制工程学。进而,提出中药质量控制工程理论模型及数字制药工程方法学,阐述了显著提升中药标准、实现中药国际化战略目标的技术路径。

关 键 词:中药质量控制  监管科学  药品生产管理  制药过程控制  药品质量控制工程学
收稿时间:2016/12/10 0:00:00

A strategy of constructing the technological system for quality control of Chinese medicine based on process control and management
CHENG Yi-yu,QIAN Zhong-zhi and ZHANG Bo-li.A strategy of constructing the technological system for quality control of Chinese medicine based on process control and management[J].China Journal of Chinese Materia Medica,2017,42(1):1-5.
Authors:CHENG Yi-yu  QIAN Zhong-zhi and ZHANG Bo-li
Institution:Department of Chinese Medicine Science & Engineering, Zhejiang University, Hangzhou 310058, China,Chinese Pharmacopoeia Commission, Beijing 100061, China and Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China;China Academy of Chinese Medical Sciences, Beijing 100700, China
Abstract:The current situation, bottleneck problems and severe challenges in quality control technology of Chinese Medicine (CM) are briefly described. It is presented to change the phenomenon related to the post-test as the main means and contempt for process control in drug regulation, reverse the situation of neglecting the development of process control and management technology for pharmaceutical manufacture and reconstruct the technological system for quality control of CM products. The regulation and technology system based on process control and management for controlling CM quality should be established to solve weighty realistic problems of CM industry from the root causes, including backwardness of quality control technology, weakness of quality risk control measures, poor reputation of product quality and so on. By this way, the obstacles from poor controllability of CM product quality could be broken. Concentrating on those difficult problems and weak links in the technical field of CM quality control, it is proposed to build CMC (Chemistry, Manufacturing and Controls) regulation for CM products with Chinese characteristics and promote the regulation international recognition as soon as possible. The CMC technical framework, which is clinical efficacy-oriented, manufacturing manner-centered and process control-focused, was designed. To address the clinical characteristics of traditional Chinese medicine (TCM) and the production feature of CM manufacture, it is suggested to establish quality control engineering for CM manufacturing by integrating pharmaceutical analysis, TCM chemistry, TCM pharmacology, pharmaceutical engineering, control engineering, management engineering and other disciplines. Further, a theoretical model of quality control engineering for CM manufacturing and the methodology of digital pharmaceutical engineering are proposed. A technology pathway for promoting CM standard and realizing the strategic goal of CM internationalization is elaborated.
Keywords:quality control of Chinese medicine  regulatory science  management of drug manufacturing  process control of pharmaceutical manufacture  quality control engineering for drug manufacturing
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号